Vita Life Sciences Limited VLS
ASX · Australia · Health Technology
AUD 2.74-0.01 (-0.36%)
Market closed· · AUD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · AUD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Total return, dividends included.
Where the price sits against its 50- and 200-day moving averages.
Makkler Fair Value, financial health score, analyst view, peers and MakklerAI.
Global bond yields have surged to multi decade highs, which raises funding costs for many companies and keeps share prices choppy. Reliable Australian dividend payers with 5%+ yields can look more attractive when income from bonds and cash improves, but still comes with their own risks. This piece highlights three long running dividend payers from our income screener that may appeal to investors who want consistency and regular cash flow. The stocks highlighted below are just a small sample...
The Australian market is poised for a potential rebound today, with futures indicating a possible one percent increase despite Wall Street's recent lackluster performance. Amidst these fluctuations, investors are increasingly turning their attention to penny stocks—smaller or newer companies that offer growth opportunities at lower price points. Although the term "penny stock" might seem outdated, these investments can still present valuable prospects when backed by robust financial health...
The Australian market is experiencing a mixed performance, with recent fluctuations influenced by global events such as rising oil prices and geopolitical tensions. Despite these challenges, the allure of penny stocks remains strong for investors seeking opportunities in smaller or newer companies. Although the term 'penny stock' might seem outdated, these stocks can offer affordability and growth potential when backed by solid financials.
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.